![](https://endpts.com/wp-content/uploads/2022/01/jpm-oncology-rd-panel-scaled.jpg)
#JPM22: Highlights for the year ahead in oncology R&D — What's hot, what's not?
Across the broad spectrum of oncology drug development, 2021 marked a year of breakthroughs with off-the-shelf cell therapies coming into their own (with some questions) …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.